CDKN2A and Parkinson disease: Moreover, the cyclin-dependent kinase inhibitor 2A, Cdkn2a, was downregulated in the brains of PD animals treated with SR3677 alone and sEV-SR3677 by 2-fold and 1-fold respectively.